Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Uveal Melanoma × Ipilimumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 3 Melanoma 2 Carcinoma, Renal Cell 2 Carcinoma, Hepatocellular 2 Various Advanced Cancer 1 Uveal Melanoma 1 Urothelial Cancer 1 Stomach Neoplasms 1 Microsatellite Unstable Colorectal Cancer 1 Mesothelioma 1 Colorectal Neoplasms 1 Advanced or Metastatic Solid Tumors 1 Adenocarcinoma Of Esophagus 1

Interventions

pembrolizumab 1 Melphalan 1 Ipilimumab 1 Dacarbazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03070392 2026-03-17

Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma

Immunocore Ltd

Phase 2 Completed

378 enrolled 15 charts 1 FDA

Uveal Melanoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡